Achieving eTMF Success and Inspection Readiness” Matthias Poensgen, Clinical Expert at ArisGlobal Speaks at Trial Master File Summit
MIAMI, FLORIDA. January 11, 2018, 2017 -- ArisGlobal, a leading ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
MIAMI, FLORIDA. January 11, 2018, 2017 -- ArisGlobal, a leading ...
Changing leadership will rapidly advance company’s focus on LifeSphere® cognitive ...
LifeSphere Safety MultiVigilance is the first pharmacovigilance solution (version 7.4.1.1-HF1) to have successfully completed E2B R3 testing with the XCOMP EudraVigilance system. Organizations using this same tested version should contact the European Medicines Agency and confirm that step 5b can be performed by themselves without the need for confirmation by the Agency.
ArisGlobal today announced that a top-five global life sciences company based in the U.S. selected ArisGlobal’s LifeSphere Safety cloud solution suite as its enterprise-level pharmacovigilance and drug safety software platform to enhance their capabilities to deliver health and wellness outcomes to waiting patients around the globe and across all business units: pharmaceutical, medical devices and consumer packaged goods.
CHICAGO, IL. APRIL 7, 2017--ArisGlobal, LLC, a global leader in ...
Self-service capabilities deliver improved compliance, process efficiency and operational effectiveness ...
Multi-tenant cloud solution acts as front end to any safety database and integrates with mobile-based applications to automate and standardize the case intake process for reports received from the field, reducing costs for greater ROI
Life science organizations can be utilizing the platform’s full clinical ...
New Multi-Tenant Cloud Platform Gives Life Science Organizations Complete Clinical ...
Over 200 Life Sciences organizations worldwide are adopting ArisGlobal’s LifeSphere Safety™ multi-tenant cloud platform to achieve E2B(R3) compliance by November 2017 EMA deadline. Within that platform, ArisGlobal’s LifeSphere Safety MultiVigilance™ solution leads the way in transforming safety case management through technology and regulatory expertise.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved